Synopsis of recent research by authors named "Amber Yasmeen"
Amber Yasmeen's recent research primarily focuses on identifying prognostic and diagnostic biomarkers for various types of ovarian cancer, particularly through the study of gangliosides GD2 and GD3 and interleukin-10 levels, revealing their potential to improve oncological outcomes and diagnostic accuracy.
Her work also explores the implications of genetic factors in cancer treatment resistance and patient survival, as seen in her studies on PARG inhibitors and the loss of SMARCA4/2 in ovarian cancer.
Furthermore, Yasmeen investigates the role of viral co-infections in other cancer types, such as colorectal cancer, showcasing her broad interest in cancer biology across different specialties.